In addition to studies on tumor, in SLE, Wu et al. discovered that CX-5461, a selective RNA polymerase I inhibitor, specifically triggers ferroptosis in B cells through the p53-SLC7A11-ALOX12 pathway and treats SLE without any pathogenic effects on vital organs [76]. Here, SLC7A11 is linked to systemic lupus erythematosus.